不当行为
科学不端行为
心理学
犯罪学
业务
会计
政治学
法学
医学
病理
替代医学
作者
Qifeng Zhao,Dongmin Kong,Qianfeng Luo
标识
DOI:10.1016/j.pacfin.2024.102547
摘要
This study examines the relationship between scientific disclosure and corporate misconduct. Through an analysis of comprehensive databases containing core journal publications and documented misconduct cases, we established a significant negative correlation between scientific disclosure and corporate misconduct. This association is particularly evident in firms with publications in English-language core journals. Our findings are corroborated by a series of rigorous robustness tests, including change analyses, instrumental variable estimation , Heckman's two-stage method, and the difference-in-differences approach. Moreover, our investigation into potential mechanisms reveals several pathways through which scientific disclosure may mitigate misconduct. These mechanisms include the attraction of high-quality talent, promotion of technological innovation, establishment of a positive reputation, acquisition of R&D subsidies, and deterrence of opportunistic corporate cultures. Ultimately, our results contribute to a more nuanced understanding of the role of corporate scientific disclosure in reducing misconduct and highlight the beneficial effects of corporate investment in scientific research. • Scientific disclosure reduces the likelihood of corporate misconduct. • Scientific disclosure is an important driving force for corporate innovation. • Scientific disclosure improves corporate transparency. • The Chinese government supports companies' scientific disclosure to reduce misconduct.
科研通智能强力驱动
Strongly Powered by AbleSci AI